FOR IMMEDIATE RELEASE:
Toronto, Ontario, Canada, August 1, 2008 - Vivosonic Inc., the Toronto-based developer and manufacturer of the world’s only Auditory Evoked Response system enabling non-sedated ABR is pleased to announce the release of its Integrity™ Version 4.5.
The Integrity™ system reduces the effects of physiological artefacts, enabling clinicians to test non-sedated, even active patients, making it an essential clinical tool for testing physically and mentally challenged adults, patients with Autism, Cerebral palsy, Sleep Apnea, Alzheimer’s and Parkinson diseases, and pacemakers. Protection against electromagnetic interferences enables clear results in places like the NICU, SCBU, and Operating Room.
“This latest version of the Integrity™ system is a new milestone in elevating the level of hearing healthcare. It helps clinicians provide care to kids with no risks and costs associated with sedation and general anesthesia – in private clinics, hospitals, schools, and research centers”, says Dr. Yuri Sokolov, President and CEO. “The new techniques we implemented in Version 4.5 further the unique clinical benefits of Integrity™”. Its new, patent-pending technique improves confidence in ABR waveform repeatability and response presence, reduced noise and stimulus artefacts, and also introduces state-of-the-art printing functionality that sets a new industry standard for reporting.
As our satisfied customers have explained it, Integrity™ is “a must have for any clinic seeing infants, children, or hard-to-test patients regardless of the existing equipment.” With Version 4.5, Integrity™ customers will continue to be able to test patients who cannot be tested with conventional ABR systems without sedation or anesthesia and in environments where achieving clear results was almost impossible.
Auditory Brainstem Response
Auditory brainstem response (ABR) is a very faint electrical potential
evoked from the auditory nerve and brainstem by the presentation of a
sound such as a click or tone burst. ABR audiometry is a test to detect
a hearing loss, especially in newborns, as well as to assess the
functions of the ears, auditory nerve, and various brain functions. ABR
is also used to estimate hearing thresholds for further intervention
such as hearing aid fitting or considering a cochlear implant.
ABR audiometry is a safe and painless test, but, due to muscle artifacts that interfere with the ABR, conventional ABR equipment often requires sedation or general anesthesia in children 3 months to 4-6 years of age.
